These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The mechanism of 8-Cl-cAMP action. Juranić Z, Radulović S, Joksimović J, Juranić I. J Exp Clin Cancer Res; 1998 Sep; 17(3):269-75. PubMed ID: 9894761 [Abstract] [Full Text] [Related]
3. Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine. Taylor CW, Yeoman LC. Anticancer Drugs; 1992 Oct; 3(5):485-91. PubMed ID: 1450443 [Abstract] [Full Text] [Related]
4. Combined activity of interleukin-1 alpha or TNF-alpha and doxorubicin on multidrug resistant cell lines: evidence that TNF and DXR have synergistic antitumor and differentiation-inducing effects. Borsellino N, Crescimanno M, Flandina C, Flugy A, D'Alessandro N. Anticancer Res; 1994 Oct; 14(6B):2643-8. PubMed ID: 7872695 [Abstract] [Full Text] [Related]
6. 8-Cl-adenosine is an active metabolite of 8-Cl-cAMP responsible for its in vitro antiproliferative effects on CHO mutants hypersensitive to cytostatic drugs. Robbins SK, Houlbrook S, Priddle JD, Harris AL. Cancer Chemother Pharmacol; 2001 Dec; 48(6):451-8. PubMed ID: 11800025 [Abstract] [Full Text] [Related]
8. Anti-proliferative effects of 8-chloro-cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression. Lamb D, Steinberg RA. J Cell Physiol; 2002 Aug; 192(2):216-24. PubMed ID: 12115728 [Abstract] [Full Text] [Related]
11. Ex vivo cytotoxic drug evaluation by DiSC assay to expedite identification of clinical targets: results with 8-chloro-cAMP. Bosanquet AG, Burlton AR, Bell PB, Harris AL. Br J Cancer; 1997 Aug; 76(4):511-8. PubMed ID: 9275029 [Abstract] [Full Text] [Related]
12. 8-Cl-cAMP and its metabolite, 8-Cl-adenosine induce growth inhibition in mouse fibroblast DT cells through the same pathways: protein kinase C activation and cyclin B down-regulation. Ahn YH, Jung JM, Hong SH. J Cell Physiol; 2004 Nov; 201(2):277-85. PubMed ID: 15334662 [Abstract] [Full Text] [Related]
13. 8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts. Noguchi K, Murata T, Cho-Chung YS. Eur J Cancer; 1998 Jul; 34(8):1260-7. PubMed ID: 9849489 [Abstract] [Full Text] [Related]
14. Proliferation of nontransformed cells is inhibited by adenosine metabolite of but not by parental 8-Cl-cyclic AMP. Han Z, Chatterjee D, Wyche JH. J Pharmacol Exp Ther; 1993 May; 265(2):790-4. PubMed ID: 8388460 [Abstract] [Full Text] [Related]
15. Genome-wide expression profiling of 8-chloroadenosine- and 8-chloro-cAMP-treated human neuroblastoma cells using radioactive human cDNA microarray. Park GH, Choe J, Choo HJ, Park YG, Sohn J, Kim MK. Exp Mol Med; 2002 Jul 31; 34(3):184-93. PubMed ID: 12216110 [Abstract] [Full Text] [Related]
16. 8-Cl-adenosine mediated cytotoxicity and sensitization of T-lymphoblastic leukemia cells to TNFalpha-induced apoptosis is via inactivation of NF-kappaB. Yin Y, Allen PD, Jia L, Kelsey SM, Newland AC. Leuk Res; 2001 May 31; 25(5):423-31. PubMed ID: 11301111 [Abstract] [Full Text] [Related]
17. 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells. Ahn YH, Jung JM, Hong SH. Cancer Res; 2005 Jun 01; 65(11):4896-901. PubMed ID: 15930311 [Abstract] [Full Text] [Related]
18. 8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo. Carlson CC, Chinery R, Burnham LL, Dransfield DT. Neoplasia; 2000 Jun 01; 2(5):441-8. PubMed ID: 11191111 [Abstract] [Full Text] [Related]
19. Antiproliferative and chemomodulatory effects of interferon-gamma on doxorubicin-sensitive and -resistant tumor cell lines. Borsellino N, Crescimanno M, Flandina C, Leonardi V, Rausa L, D'Alessandro N. Anticancer Drugs; 1993 Apr 01; 4(2):265-72. PubMed ID: 8490205 [Abstract] [Full Text] [Related]
20. Effect of buthionine sulfoximine on the sensitivity to doxorubicin of parent and MDR tumor cell lines. Crescimanno M, Borsellino N, Leonardi V, Flandina C, Flugy A, Rausa L, D'Alessandro N. J Chemother; 1994 Oct 01; 6(5):343-8. PubMed ID: 7861199 [Abstract] [Full Text] [Related] Page: [Next] [New Search]